Liminatus Pharma, Inc. (LIMN)
NASDAQ: LIMN · Real-Time Price · USD
24.22
-0.38 (-1.54%)
At close: Jun 6, 2025, 4:00 PM
21.38
-2.84 (-11.73%)
Pre-market: Jun 9, 2025, 9:08 AM EDT
Liminatus Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 |
| Jun '25 Jun 6, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 630 | 80 | 75 | 349 |
| Market Cap Growth | -77.06% | 6.12% | -78.38% | - |
| Enterprise Value | 650 | 97 | - | - |
| Last Close Price | 24.22 | 11.22 | 10.33 | 10.12 |
| PB Ratio | - | -4.14 | -4.78 | -32.30 |
| Debt / Equity Ratio | -1.03 | -1.03 | -1.02 | -1.53 |
| Quick Ratio | 0.00 | 0.00 | 0.03 | 0.29 |
| Current Ratio | 0.21 | 0.21 | 0.12 | 0.39 |
| Return on Assets (ROA) | -54.41% | -54.41% | -66.30% | - |
| Return on Capital (ROIC) | -468.22% | -468.22% | -101.31% | - |
| Earnings Yield | -0.56% | -4.43% | -6.60% | -0.84% |
| Buyback Yield / Dilution | -215.62% | -9.49% | -188.25% | - |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.